地高辛联合倍他乐克治疗充血性心衰伴快速房颤患者的疗效观察

Therapeutic Effect of Digoxin Combined with Betaloc in the Treatment of Patients with Congestive Heart Failure and Rapid Atrial Fibrillation

目的:探讨地高辛联合倍他乐克在治疗充血性衰伴快速房颤患者时的功能与价值。方法:选取某院2017年2月~2019年2月期间收治的充血性心衰伴快速房颤患者共计100例,根据科学分组的方法划分为对照组与观察组,针对对照组采取常规治疗与护理,观察组患者在此基础上实施地高辛联合倍他乐克治疗,对比两组患者临床治疗有效性以及并发症发病率、左心室射血分数。结果:通过研究对比发现,观察组患者总有效率高于对照组患者(P<0.05);在并发症发病率方面,观察组患者优于对照组患者(P<0.05);左心室射血分数方面,观察组同样优于对照组(P<0.05)。结论:针对充血性衰伴快速房颤患者采取地高辛联合倍他乐克治疗具有良好的效果,可以显著改善患者的左心室射血分数,同时对于抑制并发症以及提升预后等方面都具有良好的效果,建议在临床上应用并推广使用。

Objective:To investigate the function and value of digoxin combined with betaloc in the treatment of patients with congestive failure and rapid atrial fibrillation.Methods:A total of 100 patients with congestive heart failure and rapid atrial fibrillation admitted to a hospital from February 2017 to February 2019 were selected and divided into the control group and the observation group according to the scientific grouping method.The routine treatment and nursing were adopted for the control group.On the basis of this,patients in the observation group were treated with digoxin plus betaloc,and the clinical efficacy and incidence of complications and left ventricular ejection fraction were compared between the two groups.Results:By comparison,the total effective rate of the observation group was higher than that of the control group(P<0.05).In terms of the incidence of complications,the observation group was superior to the control group(P<0.05),and the left ventricular ejection fraction in the observation group was also superior to the control group(P<0.05).Conclusion:The digoxin plus betaloc in the treatment of patients with congestive dysfunction and rapid atrial fibrillation haa good effects,which can significantly improve the left ventricular ejection fraction,has a good effect on inhibiting complications and improving prognosis,and is recommended to be applied and promoted in clinical practice.